- Filed
- Mar 26, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 26, 2025 | 26.9M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 29.21M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2023 | $1.6M |
| Capex restated | FY 2024 · Dec 31, 2023 | $32M |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2023 | $54.7M |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $295.6M |
| Short Term Debt | FY 2024 · Dec 31, 2023 | $19.1M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $100.7M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $418.9M |
| Current Assets restated | FY 2024 · Dec 31, 2023 | $155.7M |
| Total Assets restated | FY 2024 · Dec 31, 2023 | $343M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | $0.24 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | $0.25 |
| Rd Expense | FY 2024 · Dec 31, 2023 | $20.3M |
| Net Income restated | FY 2024 · Dec 31, 2023 | $6.9M |
| Operating Income restated | FY 2024 · Dec 31, 2023 | $38.9M |
| Revenue restated | FY 2024 · Dec 31, 2023 | $322.9M |